Drug Guide

Generic Name

Ketoprofen

Brand Names Orudis, Oruvail, Orudis Kt, Actron, Nexcede

Classification

Therapeutic: Nonsteroidal anti-inflammatory drug (NSAID)

Pharmacological: Propionic acid derivative

FDA Approved Indications

  • Relief of mild to moderate pain
  • Inflammation associated with rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis

Mechanism of Action

Ketoprofen inhibits cyclooxygenase (COX-1 and COX-2), leading to decreased formation of prostaglandins, thereby reducing inflammation, pain, and fever.

Dosage and Administration

Adult: Oral: 25-50 mg every 6-8 hours as needed; max dose typically 200 mg/day.

Pediatric: Not recommended for children under 16 due to safety profile.

Geriatric: Start at lower end of dosing range; monitor renal and hepatic function.

Renal Impairment: Adjust dose; use with caution due to increased risk of renal toxicity.

Hepatic Impairment: Use with caution; dose adjustment may be necessary.

Pharmacokinetics

Absorption: Well absorbed from the gastrointestinal tract.

Distribution: Widely distributed; crosses the placenta and enters breast milk.

Metabolism: Hepatically metabolized mainly via hydroxylation and conjugation.

Excretion: Primarily via the kidneys as metabolites; small amount excreted unchanged.

Half Life: Approximately 2 hours.

Contraindications

  • Hypersensitivity to ketoprofen or other NSAIDs
  • History of asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs.
  • Active gastrointestinal bleeding or ulceration.

Precautions

  • Use with caution in patients with cardiovascular disease, hypertension, renal or hepatic impairment.
  • Risk of gastrointestinal bleeding, ulceration, and perforation.

Adverse Reactions - Common

  • Gastrointestinal upset (nausea, dyspepsia) (Common)
  • Dizziness, headache (Common)

Adverse Reactions - Serious

  • Gastrointestinal bleeding or ulceration (Less common)
  • Cardiovascular thrombotic events (myocardial infarction, stroke) (Less common)
  • Allergic reactions (anaphylaxis, skin reactions) (Uncommon)

Drug-Drug Interactions

  • Warfarin, other anticoagulants
  • Other NSAIDs, corticosteroids—risk of bleeding
  • ACE inhibitors and diuretics—reduced efficacy and renal risks

Drug-Food Interactions

N/A

Drug-Herb Interactions

N/A

Nursing Implications

Assessment: Monitor for signs of bleeding, gastrointestinal disturbances, and renal function.

Diagnoses:

  • Risk for bleeding
  • Impaired kidney function
  • Gastrointestinal discomfort

Implementation: Administer with food or milk to decrease gastrointestinal irritation; monitor renal function periodically.

Evaluation: Assess pain relief, reduction in inflammation, and side effects.

Patient/Family Teaching

  • Take with food or milk to minimize GI upset.
  • Report unusual bleeding, stomach pain, or signs of allergic reaction.
  • Do not exceed recommended dose.
  • Avoid alcohol and smoking.

Special Considerations

Black Box Warnings:

  • Serious cardiovascular thrombotic events, including myocardial infarction and stroke, have been reported with NSAID use.
  • Gastrointestinal bleeding, ulceration, and perforation risk.

Genetic Factors: None specified.

Lab Test Interference: May increase bleeding times, affect renal function tests.

Overdose Management

Signs/Symptoms: Nausea, vomiting, epigastric pain, dizziness, and somnolence; severe cases may involve gastrointestinal bleeding or renal impairment.

Treatment: Supportive care, activated charcoal if early, monitor renal function, and treat symptoms. Hemodialysis is not typically effective.

Storage and Handling

Storage: Store at room temperature, 20-25°C (68-77°F).

Stability: Stable under recommended conditions for shelf life.

This guide is for educational purposes only and is not intended for clinical use.